Drug Shortage Report for CALCIUM GLUCONATE INJECTION, USP 10%

Last updated on 2018-04-10 History
Report ID 41540
Drug Identification Number 02141019
Brand name CALCIUM GLUCONATE INJECTION, USP 10%
Common or Proper name Calcium Gluconate Injection USP 10% 100 mg/mL
Company Name FRESENIUS KABI CANADA LTD
Active Ingredient(s) CALCIUM GLUCONATE CALCIUM SACCHARATE
Strength(s) 94MG 4.5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 mL Vial
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-03-14
Actual start date
Estimated end date 2018-04-04
Actual end date 2018-04-09
Shortage status Resolved
Updated date 2018-04-10
Company comments
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2018-04-10 English Compare
v5 2018-04-09 French Compare
v4 2018-04-09 English Compare
v3 2018-03-15 English Compare
v2 2018-03-02 French Compare
v1 2018-03-02 English Compare